Abstract: Biotherapeutic agents are provided which comprise recombinant PAP or a biologically equivalent variant or mutant thereof, linked to a targeting moiety which are effective for the treatment of certain human diseases. The invention further provides a process for producing the biotherapeutic agents as well as a method which utilizes the disclosed biotherapeutic agents to systemically treat cancer patients.
Type:
Grant
Filed:
July 11, 1995
Date of Patent:
November 14, 2000
Assignees:
Regents of the University of Minnesota and Rutgers, The State University of New Jersey